Back to Market返回行情

AVNS Avanos Medical, Inc.

USHealthcare
$24.93-0.02%ClosedMarket Cap: $1.17B

As of 2026-07-10 16:00

Why AVNS matters now

Avanos Medical, Inc. (AVNS) is a US stock in Healthcare. The latest InvestLog snapshot shows $24.93 with -0.02% on the session and $1.17B in market capitalization; recent performance reads 1-month +0.77% and YTD +122.08%.

The latest financial table shown here is Q1 2026, with revenue of $182.2M, net income of $5.1M, and EPS of $0.11. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 0.6%.

The latest indexable market news headline is "Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger" from PRNewsWire.

Additional event context on this page matters because analyst consensus is Hold with a median target of $23.00; recent insider activity includes Shimer Julie Ann filing A-Award. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

1.48

P/S

1.63

EV/EBITDA

-57.46

DCF Value

$-17.10

FCF Yield

0.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

48.6%

Operating Margin

-7.9%

Net Margin

-9.7%

ROE

-8.9%

ROA

-6.6%

ROIC

-6.0%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$182.2M$5.1M$0.11
Q4 2025$180.9M$3.7M$0.08
FY 2025$701.2M$-67.9M$-1.46
Q3 2025$177.8M$-1.4M$-0.03

Analyst Ratings

Consensus

Hold

Target (Consensus)

$23.00

Target (Median)

$23.00

Target Range

$20.00 - $26.00

Strong Buy: 0Buy: 0Hold: 1Sell: 0Strong Sell: 0

Trading Activity

Insider Trades

Shimer Julie Anndirector
Sell2026-05-12
OLEARY PATRICK Jdirector
Sell2026-05-12
Franchini Indrani Lalldirector
Sell2026-05-12
Egbuonu-Davis Lisadirector
Sell2026-05-12
BLACKFORD GARYdirector
Sell2026-05-12

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.57

Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.